MAIN STORY
Medicines change the nutritional conversation
GLP-1 medicines including Ozempic and Mounjaro can reduce appetite, bringing new attention to adequate nutrition and the preservation of muscle during weight loss. When portions become smaller, what each meal provides matters more. Protein plays an important role in maintaining body tissue, but individual requirements vary with age, activity, health and clinical circumstances. The boom should not be mistaken for a universal prescription to eat ever more protein.
An August Boston Consulting Group survey reported that users expected to spend 11% more on high-protein products than before starting treatment. Circana found about 48% of American adults were seeking to increase protein consumption, seven percentage points above the previous year. Together these findings point to considerable commercial demand, although neither establishes that every new purchase is caused by GLP-1 therapy.
The arithmetic behind the package
Protein branding now appears on products as varied as ice cream, pasta, coffee and sparkling drinks. What looks like a simple claim can be hard to compare: the large number on the front typically refers to a manufacturer-defined serving.

















